Literature DB >> 32839176

The Evolutionary Conservation of Escherichia coli Drug Efflux Pumps Supports Physiological Functions.

Tanisha Teelucksingh1, Laura K Thompson1, Georgina Cox2.   

Abstract

Bacteria harness an impressive repertoire of resistance mechanisms to evade the inhibitory action of antibiotics. One such mechanism involves efflux pump-mediated extrusion of drugs from the bacterial cell, which significantly contributes to multidrug resistance. Intriguingly, most drug efflux pumps are chromosomally encoded components of the intrinsic antibiotic resistome. In addition, in terms of xenobiotic detoxification, bacterial efflux systems often exhibit significant levels of functional redundancy. Efflux pumps are also considered to be highly conserved; however, the extent of conservation in many bacterial species has not been reported and the majority of genes that encode efflux pumps appear to be dispensable for growth. These observations, in combination with an increasing body of experimental evidence, imply alternative roles in bacterial physiology. Indeed, the ability of efflux pumps to facilitate antibiotic resistance could be a fortuitous by-product of ancient physiological functions. Using Escherichia coli as a model organism, we here evaluated the evolutionary conservation of drug efflux pumps and we provide phylogenetic analysis of the major efflux families. We show the E. coli drug efflux system has remained relatively stable and the majority (∼80%) of pumps are encoded in the core genome. This analysis further supports the importance of drug efflux pumps in E. coli physiology. In this review, we also provide an update on the roles of drug efflux pumps in the detoxification of endogenously synthesized substrates and pH homeostasis. Overall, gaining insight into drug efflux pump conservation, common evolutionary ancestors, and physiological functions could enable strategies to combat these intrinsic and ancient elements.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Escherichia colizzm321990; antibiotics; drug resistance evolution; efflux pumps; physiology

Mesh:

Substances:

Year:  2020        PMID: 32839176      PMCID: PMC7585057          DOI: 10.1128/JB.00367-20

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  159 in total

Review 1.  Microbial minimalism: genome reduction in bacterial pathogens.

Authors:  Nancy A Moran
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

Review 2.  Alkaline pH homeostasis in bacteria: new insights.

Authors:  Etana Padan; Eitan Bibi; Masahiro Ito; Terry A Krulwich
Journal:  Biochim Biophys Acta       Date:  2005-09-26

3.  The I-TASSER Suite: protein structure and function prediction.

Authors:  Jianyi Yang; Renxiang Yan; Ambrish Roy; Dong Xu; Jonathan Poisson; Yang Zhang
Journal:  Nat Methods       Date:  2015-01       Impact factor: 28.547

4.  Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic.

Authors:  P R Ball; S W Shales; I Chopra
Journal:  Biochem Biophys Res Commun       Date:  1980-03-13       Impact factor: 3.575

Review 5.  A multifaceted role for polyamines in bacterial pathogens.

Authors:  Pratik Shah; Edwin Swiatlo
Journal:  Mol Microbiol       Date:  2008-03-05       Impact factor: 3.501

6.  An efflux pump is required for siderophore recycling by Pseudomonas aeruginosa.

Authors:  Emilie Yeterian; Lois W Martin; Iain L Lamont; Isabelle J Schalk
Journal:  Environ Microbiol Rep       Date:  2009-12-21       Impact factor: 3.541

7.  Core Genes Evolve Rapidly in the Long-Term Evolution Experiment with Escherichia coli.

Authors:  Rohan Maddamsetti; Philip J Hatcher; Anna G Green; Barry L Williams; Debora S Marks; Richard E Lenski
Journal:  Genome Biol Evol       Date:  2017-04-01       Impact factor: 3.416

8.  RND multidrug efflux pumps: what are they good for?

Authors:  Carolina Alvarez-Ortega; Jorge Olivares; José L Martínez
Journal:  Front Microbiol       Date:  2013-02-05       Impact factor: 5.640

9.  Reduced selection leads to accelerated gene loss in Shigella.

Authors:  Ruth Hershberg; Hua Tang; Dmitri A Petrov
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  Characterization and regulation of the resistance-nodulation-cell division-type multidrug efflux pumps MdtABC and MdtUVW from the fire blight pathogen Erwinia amylovora.

Authors:  Daniel Pletzer; Helge Weingart
Journal:  BMC Microbiol       Date:  2014-07-11       Impact factor: 3.605

View more
  8 in total

1.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

2.  A genetic platform to investigate the functions of bacterial drug efflux pumps.

Authors:  Tanisha Teelucksingh; Laura K Thompson; Shawna Zhu; Noah M Kuehfuss; James A Goetz; Stephanie E Gilbert; Craig R MacNair; Jennifer Geddes-McAlister; Eric D Brown; Georgina Cox
Journal:  Nat Chem Biol       Date:  2022-09-05       Impact factor: 16.174

3.  Extreme Acid Modulates Fitness Trade-Offs of Multidrug Efflux Pumps MdtEF-TolC and AcrAB-TolC in Escherichia coli K-12.

Authors:  Samantha H Schaffner; Abigail V Lee; Minh T N Pham; Beimnet B Kassaye; Haofan Li; Sheetal Tallada; Cassandra Lis; Mark Lang; Yangyang Liu; Nafeez Ahmed; Logan G Galbraith; Jeremy P Moore; Katarina M Bischof; Chelsea C Menke; Joan L Slonczewski
Journal:  Appl Environ Microbiol       Date:  2021-07-27       Impact factor: 4.792

4.  Burkholderia collagen-like protein 8, Bucl8, is a unique outer membrane component of a putative tetrapartite efflux pump in Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Megan E Grund; Soo J Choi; Dudley H McNitt; Mariette Barbier; Gangqing Hu; P Rocco LaSala; Christopher K Cote; Rita Berisio; Slawomir Lukomski
Journal:  PLoS One       Date:  2020-11-23       Impact factor: 3.240

5.  Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.

Authors:  Xuan Wang-Kan; Giovanny Rodríguez-Blanco; Andrew D Southam; Catherine L Winder; Warwick B Dunn; Alasdair Ivens; Laura J V Piddock
Journal:  mBio       Date:  2021-03-30       Impact factor: 7.867

6.  Genome Informatics and Machine Learning-Based Identification of Antimicrobial Resistance-Encoding Features and Virulence Attributes in Escherichia coli Genomes Representing Globally Prevalent Lineages, Including High-Risk Clonal Complexes.

Authors:  Sabiha Shaik; Anuradha Singh; Arya Suresh; Niyaz Ahmed
Journal:  mBio       Date:  2022-02-15       Impact factor: 7.867

7.  Characterization and Comparative Genomic Analysis of a Highly Colistin-Resistant Chryseobacterium gallinarum: a Rare, Uncommon Pathogen.

Authors:  Mahendra Gaur; Suchanda Dey; Anshuman Sahu; Sangita Dixit; S Sarathbabu; John Zothanzama; Rajesh Kumar Sahoo; Dibyajyoti Uttameswar Behera; Enketeswara Subudhi
Journal:  Front Cell Infect Microbiol       Date:  2022-07-14       Impact factor: 6.073

Review 8.  Research Progress on Antibacterial Activities and Mechanisms of Natural Alkaloids: A Review.

Authors:  Yumei Yan; Xing Li; Chunhong Zhang; Lijuan Lv; Bing Gao; Minhui Li
Journal:  Antibiotics (Basel)       Date:  2021-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.